Abstract: Modular wireless switch system for use in an aircraft, which may include an integrated LED backlight. The system includes a master module having a power supply, a switch, and a wireless communicator configured to communicate a switch state. The system also includes a slave module connectable to the master module, which has a second switch and which is configured to communicate a second switch state using the wireless communicator. All wireless communications may be handled by the master module using a protocol such as ZigBee™. All communications from the slave module may be transmitted to the master module via a wired bus. Additional slave modules are connectable to the bus as desired.

Abstract: Modular wireless switch system for use in an aircraft, which may include an integrated LED backlight. The system includes a master module having a power supply, a switch, and a wireless communicator configured to communicate a switch state. The system also includes a slave module connectible to the master module, which has a second switch and which is configured to communicate a second switch state using the wireless communicator. All wireless communications may be handled by the master module using a protocol such as ZigBee™. All communications from the slave module may be transmitted to the master module via a wired bus. Additional slave modules are connectible to the bus as desired.

Abstract: A compound of general formula I their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances of CaSR activity, such as hyperparathyroidism, pharmaceutical compositions comprising said compounds, methods of treating diseases with said compounds, and the use of said compounds in the manufacture of medicaments.

Abstract: The invention relates to novel compounds according to formula Ia and Ib; (Formula Ia and Ib) wherein A represents substituted or unsubstituted C1-10heteroaryl, C6-14aryl or C6-10heterocycloalkylaryl; R1 is C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6hydroxyalkyl, C1-6haloalkyl, C1-6amino, C3-6 cycloalkyl, or C1-6heterocycloalkyl, each of which are optionally substituted; X represents —CR3R4—(CR5R6)n—(CR7?CR8)m—(C6-14aryl)r-(C1-10heteroaryl)s-(CR9R10)p—(CR11?CR12)q, R2 represents C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6hydroxyalkyl, C1-6haloalkyl, C1-6amino, C1-12alkylsilyl, C6-30alkylarylsilyl, C1-10heteroaryl, C6-14aryl, C1-10heterocycloalkyl, C1-10heterocycloalkenyl, C1-8cycloalkyl, C1-18cycloalkenyl, each of which is optionally substituted, or R2 represents hydrogen, carboxy, or hydroxy; or a pharmaceutically acceptable salt, solvate, or ester thereof; to processes for the preparation thereof, to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, wherein said compoun

Abstract: Ceramic nanofiltration membrane for use with organic solvents is produced by impregnating a mesoporous ceramic membrane with a hydrophobing agent.

Abstract: Novel cyclo azaphospha hydrocarbons according to formula I are provided. The compounds are useful as metalloprotease inhibitors.

Abstract: Novel cyclo azaphospha hydrocarbons according to formula I 1